332 related articles for article (PubMed ID: 11940053)
1. Galanin in human pituitary adenomas: frequency and clinical significance.
Leung B; Iisma TP; Leung KC; Hort YJ; Turner J; Sheehy JP; Ho KK
Clin Endocrinol (Oxf); 2002 Mar; 56(3):397-403. PubMed ID: 11940053
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
4. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
5. Presence of galanin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary.
Vrontakis ME; Sano T; Kovacs K; Friesen HG
J Clin Endocrinol Metab; 1990 Mar; 70(3):747-51. PubMed ID: 1689739
[TBL] [Abstract][Full Text] [Related]
6. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D and cyclin E expression in normal and adenomatous pituitary.
Jordan S; Lidhar K; Korbonits M; Lowe DG; Grossman AB
Eur J Endocrinol; 2000 Jul; 143(1):R1-6. PubMed ID: 10870044
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases.
Sano T; Kovacs K; Asa SL; Smyth HS
Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):361-7. PubMed ID: 2173251
[TBL] [Abstract][Full Text] [Related]
9. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
10. Galanin in the normal human pituitary and brain and in pituitary adenomas.
Bennet WM; Hill SF; Ghatei MA; Bloom SR
J Endocrinol; 1991 Sep; 130(3):463-7. PubMed ID: 1719117
[TBL] [Abstract][Full Text] [Related]
11. Direct intraoperative micromethod for hormone measurements of pituitary tissue in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Surg Neurol; 1999 Dec; 52(6):585-90; discussion 590-1. PubMed ID: 10660024
[TBL] [Abstract][Full Text] [Related]
12. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
13. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
14. The release of leptin and its effect on hormone release from human pituitary adenomas.
Korbonits M; Chitnis MM; Gueorguiev M; Norman D; Rosenfelder N; Suliman M; Jones TH; Noonan K; Fabbri A; Besser GM; Burrin JM; Grossman AB
Clin Endocrinol (Oxf); 2001 Jun; 54(6):781-9. PubMed ID: 11422113
[TBL] [Abstract][Full Text] [Related]
15. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.
Orth DN; Nicholson WE
Endocrinology; 1982 Aug; 111(2):559-63. PubMed ID: 6284484
[TBL] [Abstract][Full Text] [Related]
16. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
[TBL] [Abstract][Full Text] [Related]
17. Surgical remission of pituitary adenomas confined to the neurohypophysis in Cushing's disease.
Weil RJ; Vortmeyer AO; Nieman LK; Devroom HL; Wanebo J; Oldfield EH
J Clin Endocrinol Metab; 2006 Jul; 91(7):2656-64. PubMed ID: 16636117
[TBL] [Abstract][Full Text] [Related]
18. Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease.
Tan EU; Ho MS; Rajasoorya CR
Pituitary; 2000 Oct; 3(2):117-22. PubMed ID: 11141695
[TBL] [Abstract][Full Text] [Related]
19. Histopathology of the pituitary.
Doniach I
Clin Endocrinol Metab; 1985 Nov; 14(4):765-89. PubMed ID: 3002676
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological study of Cushing's disease with large pituitary adenoma.
Ikeda H; Yoshimoto T; Ogawa Y; Mizoi K; Murakami O
Clin Endocrinol (Oxf); 1997 Jun; 46(6):669-79. PubMed ID: 9274697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
